乳がんのアウトカムに関する農村と所得:SEERデータベースの分析
Suniah Ayub1, Angelo Marra2, Yuan Liu2
1Department of Surgery and Winship Cancer Institute, Emory Winship Cancer Institute at ESJH, Emory University, Atlanta, GA, USA. sayub@emory.edu.
Annals of surgical oncology
|February 19, 2026
まとめ
低所得の田舎の乳がん患者は,都市部の人と比較して,診断と治療の格差に直面しています. 農村と収入の複雑な相互作用を理解することは,これらの健康上の不平等に対処するために不可欠です.
科学分野:
- 腫瘍学 腫瘍学
- 健康格差 研究 研究
- エピデミオロジー エピデミオロジー
背景:
- 乳がんのアウトカムは,社会経済的な地位と地理的な位置によって大きく異なります.
- 乳がん患者のアウトカムに対する農村と収入の組み合わせによる影響に関する研究は限られている.
- これらの複雑な相互作用を理解するために,国家レベルのデータが必要です.
研究 の 目的:
- 住居の田舎性と所得水準が乳がんの臨床表現と治療パターンに及ぼす相互作用を調査する.
- 乳がんのケアにおける格差を特定し,農村と低所得層の状況の交差に関連付けます.
- 乳がんの不平等を減らすことを目的とした将来の介入のためのデータを提供する.
主な方法:
- 乳がんの診断のために,国立がん研究所の監視,疫学,および最終結果 (SEER) プログラム (2004-2020) を利用しました.
- SEERのRural-Urban Continuum Codesを使用して,患者の所在地を農村または都市に分類しました.
- 収入が低い (≤5万5千ドル) または高い (>5万5千ドル) と定義され,農村地域と所得によって層格化されています.
主要な成果:
- 815,220例のうち,57,063例は農村低所得者 (RLI),55,667例は都市低所得者 (ULI),29,762例は農村高所得者 (RHI),672,728例は都市高所得者 (UHI) であった.
- RLI患者は,局所疾患と診断される可能性が高く,ULI患者と比較して診断時に年上でした.
- ULI患者は,エストロゲン受容体陰性およびHER2陽性疾患のより高い割合を示し,RLI患者と比較してより多くの腫瘍切除,化学療法,放射線治療を受けた.
結論:
- 収入レベルと居住環境の両方が,乳がんの臨床表現と治療の格差と独立して関連しています.
- 農村と収入の相互作用は,乳がんのアウトカムに大きな影響を及ぼし,さらなる調査を必要としています.
- これらの格差の地理空間的分布を理解することは,ターゲットを絞った介入の開発に不可欠です.
関連する概念動画
Cancer Survival Analysis
788
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
788
Statistical Methods for Analyzing Epidemiological Data
1.0K
Epidemiological data primarily involves information on specific populations' occurrence, distribution, and determinants of health and diseases. This data is crucial for understanding disease patterns and impacts, aiding public health decision-making and disease prevention strategies. The analysis of epidemiological data employs various statistical methods to interpret health-related data effectively. Here are some commonly used methods:
1.0K
Comparing the Survival Analysis of Two or More Groups
637
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
637
Rous Sarcoma Virus (RSV) and Cancer
6.5K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
6.5K
Bias in Epidemiological Studies
1.4K
Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:
1.4K
Kaplan-Meier Approach
648
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
648


